Radhika Tripuraneni's Net Worth

$0

Estimate Recalculated Sep 17, 2024 06:50PM EST

Who is Radhika Tripuraneni?

Radhika Tripuraneni does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prothena Corp plc, and Terns Pharmaceuticals, Inc..

SEC CIK

Radhika Tripuraneni's CIK is 0001761114

Past Insider Trading and Trends

2021 was Radhika Tripuraneni's most active year for acquiring shares with 2 total transactions. Radhika Tripuraneni's most active month to acquire stocks was the month of January. 2021 was Radhika Tripuraneni's most active year for disposing of shares, totalling 1 transactions. Radhika Tripuraneni's most active month to dispose stocks was the month of January. 2020 saw Radhika Tripuraneni paying a total of $0.00 for 70,000 shares, this is the most they've acquired in one year. In 2021 Radhika Tripuraneni cashed out on 50,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PROTHENA CORP PUBLIC LTD CO (PRTA) Snapshot price: $20.33

Chief Development Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Feb 27
Form 4
—
0
—
—
0
Dec 11
Form 3
—
0
—
—
0
No matching records found

Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $7.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jul 26
Form 3
—
0
—
—
0
No matching records found